The Liquid Biopsy That Found Pancreatic Cancer Early Has a Bigger Regulatory Problem Than Its Science
The Liquid Biopsy That Found Pancreatic Cancer Early Has a Bigger Regulatory Problem Than Its Science The Clinical Trial Vanguard
1140 материалов по теме, собраны автоматически из проверенных источников
The Liquid Biopsy That Found Pancreatic Cancer Early Has a Bigger Regulatory Problem Than Its Science The Clinical Trial Vanguard
$1 Million Raised at the 3rd Annual V Foundation for Cancer Research Chicago Epicurean Oncodaily
New centre for immuno-oncology at Karolinska Institutet to bring cancer research closer to new treatments The National Tribune
Phase 2 trial suggests vitamin C may benefit people with pre-cancer blood disorders Van Andel Institute
New centre for immuno-oncology at Karolinska Institutet to bring cancer research closer to new treatments nationaltribune.com.au
Vitamin C boosts the activity of cellular proteins called TET enzymes that help control which genes are turned on or off. Because decreased function of TET enzymes is a common driver of certain forms of blood cancer, researchers tested the effects of vitamin C supplements in patients at risk of developing such…
Antengene Starts Phase III CLINCH-3 Trial of ATG-022 in Advanced Gastric Cancer The Clinical Trial Vanguard
Listed cancer treatment developer Prescient raising to fund trials AFR
A sweeping review of more than 153,000 adults found that calcium and vitamin D supplements, alone or together, do little to prevent fractures or falls in most older people. Researchers say the findings challenge routine supplementation for prevention and point instead toward strategies such as balance and resistance…
Money Worries Are the Blind Spot in Cancer Survivorship Care, Study Finds Bioengineer.org
China’s Cancer Research Shifts From Molecular Reductionism to Holistic Integrative Medicine Bioengineer.org
AI-Powered Cancer Drug Research Has Exploded Since 2018, Landmark 15,554-Study Analysis Reveals Bioengineer.org
Researchers have successfully conducted the first clinical trial using activated regulatory T cells (ATregs, Actileucel)—derived from white blood cells of healthy blood donors. This novel cell therapy aims to prevent graft-versus-host disease (GvHD) following an allogeneic stem cell transplant. The Phase I/II study…
Woman with four cancers in 40 years says trial drug shrank tumour BBC
Woman with four cancers in 40 years says trial drug shrank tumour BBC